Kallikrein 2 Antibody

Kallikreins are a group of serine proteases manifesting diverse physiological functions. The glandular kallikreins are a distinct group of serine proteases with an ability to release vasoactive peptides from kininogen in vitro, although the kininogenase activity of different kallikreins is highly variable. Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin. Many kallikrein genes are differentially expressed in various malignancies. Human glandular kallikrein (hK2; encoded by the KLK2 gene) is an emerging tumor marker for prostate cancer.

This Kallikrein 2 (KLK2) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 166-197 amino acids from the C-terminal region of human Kallikrein 2 (KLK2) .

Store at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Haese, A., et al., Urol. 2005 Mar;173 (3) :752-6. Chiang, C.H., et al., Urol. 2005 Feb;173 (2) :429-32. Clements, J.A., et al., Crit Rev Clin Lab Sci. 2004;41 (3) :265-312. Borgono, C.A., et al., Mol Cancer Res. 2004 May;2 (5) :257-80. Yousef, G.M., Clin Biochem. 2003 Sep;36 (6) :443-52.